Zoetis | ZTS - Equity Capital And Reserves



Zoetis reported $4.98B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
Align Technology USD 3.79B 57.74M Mar/2025
Bayer EUR 30.5B 2.08B Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Charles River Laboratories USD 3.31B 119.03M Jun/2025
Dentsply International USD 1.96B 50M Jun/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Henry Schein USD 3.44B 135M Jun/2025
Idexx Laboratories USD -4410277000 5.86B Jun/2025
Illumina USD 2.26B 110M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Laboratory Of America USD 8.47B 151M Jun/2025
Merck USD 49.06B 725M Jun/2025
Neogen USD 2.07B 589.09M May/2025
Pacira USD 757.77M 40.77M Jun/2025
Perrigo USD 4.47B 108.3M Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Quest Diagnostics USD 7.23B 299M Jun/2025
Sanofi 70.28B 3.8B Jun/2025
Sanofi 70.28B 7.58B Jun/2025
Zoetis USD 4.98B 322M Jun/2025